A randomised dose-finding phase II study on ifosfamide in metastatic hormone-refractory prostate cancer (HRPC)

P Hervonen, T Lehtinen, TL Tammela, P Kellokumpu-Lehtinen

    Research output: Contribution to journalArticleScientificpeer-review

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)177-180
    JournalJ Exp Clin Cancer Res
    Volume21
    Issue number2
    Publication statusPublished - 2002
    Publication typeA1 Journal article-refereed

    Keywords

    • hormone-resistant
    • palliation

    Cite this